Atea Pharmaceuticals, Inc. (AVIR) Insider Trading

Name: Atea Pharmaceuticals, Inc. (AVIR) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 23, 2026): Lucidi Bruno (Director): Exercise/Conversion of 29,600 shares.

Get alerted when insiders trade AVIR

Email address

Loading company data...

Beta

Loading company details...

Beta